University Medical Center Ljubljana

Transplant Infectious Disease

Clinical research at University Medical Center Ljubljana is centered on cytomegalovirus management in heart transplant recipients, with attention to post-transplant viral prevention and infection control.

  • CMV infection in heart transplant recipients
  • CMV prophylaxis
  • Post-transplant infection prevention

The sponsor’s current trial activity reflects a focused interest in protecting transplant patients from viral complications during the vulnerable period after cardiac transplantation.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Letermovir for Preventing Cytomegalovirus in Heart Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Slovenia